Aluminum-doped zinc oxide nanoparticles attenuate the TSLP levels via suppressing caspase-1 in activated mast cells

Journal of Biomaterials Applications

Volumn 30, Issue 9, 2016, Pages 1407-1416

  Kim, Min Ho ^a   Seo, Jun Ho ^b   Kim, Hyung Min ^c   Jeong, Hyun Ja ^d  

^a Department of Clinical Pathology   (South Korea)

^b Chonbuk National University   (South Korea)

^c Kyung Hee University   (South Korea)

^d Hoseo University   (South Korea)

Author keywords

Aluminum doped zinc oxide nanoparticles; caspase 1; mast cells; TSLP

Indexed keywords

ALUMINUM; CELL CULTURE; CELLS; CHEMICAL ACTIVATION; CYTOLOGY; ENZYME ACTIVITY; ENZYMES; NANOPARTICLES; OPTICAL FILMS; PROTEINS; ZINC;

ALUMINUM-DOPED ZINC OXIDE; CASPASE-1; EXTRACELLULAR SIGNAL-REGULATED KINASE; MAST CELLS; MITOGEN ACTIVATED PROTEIN KINASE; RECEPTOR-INTERACTING PROTEINS; TSLP; ZINC OXIDE NANOPARTICLES;

ZINC OXIDE;

ALUMINUM; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; THYMIC STROMAL LYMPHOPOIETIN; TUMOR NECROSIS FACTOR ALPHA; ZINC OXIDE NANOPARTICLE; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; CYTOKINE; NANOPARTICLE; TUMOR NECROSIS FACTOR; ZINC OXIDE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL LINE; CHEMICAL PROCEDURES; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HMC 1 CELL; HUMAN; HUMAN CELL; MAST CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; CHEMISTRY; DRUG EFFECTS; IMMUNOLOGY;

ALUMINUM; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; CASPASE 1; CELL LINE; CYTOKINES; ENZYME ACTIVATION; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; MAST CELLS; NANOPARTICLES; TUMOR NECROSIS FACTOR-ALPHA; ZINC OXIDE;

EID: 84961708273     PISSN: 08853282     EISSN: 15308022     Source Type: Journal    
DOI: 10.1177/0885328216629822     Document Type: Article

References (49)

1. Aydin Sevinc B, Hanley L,. Antibacterial activity of dental composites containing zinc oxide nanoparticles. J Biomed Mater Res B Appl Biomater 2010; 94: 22-31.
2. Kim MH, Seo JH, Kim HM, et al. Zinc oxide nanoparticles, a novel candidate for the treatment of allergic inflammatory diseases. Eur J Pharmacol 2014; 738: 31-39.
3. Rasmussen JW, Martinez E, Louka P, et al. Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expert Opin Drug Deliv 2010; 7: 1063-1077.
4. Yamaki K, Yoshino S,. Comparison of inhibitory activities of zinc oxide ultrafine and fine particulates on IgE-induced mast cell activation. Biometals 2009; 22: 1031-1040.
5. Jeong SH, Kim HJ, Ryu HJ, et al. ZnO nanoparticles induce TNF-α expression via ROS-ERK-Egr-1 pathway in human keratinocytes. J Dermatol Sci 2013; 72: 263-273.
6. Bosco MD, Mohanasundaram DM, Drogemuller CJ, et al. Zinc and zinc transporter regulation in pancreatic islets and the potential role of zinc in islet transplantation. Rev Diabet Stud 2010; 7: 263-274.
7. Hanley C, Thurber A, Hanna C, et al. The influences of cell type and ZnO nanoparticle size on immune cell cytotoxicity and cytokine induction. Nanoscale Res Lett 2009; 4: 1409-1420.
8. Frohlich E,. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomed 2012; 7: 5577-5591.
9. Wilson WW, Wade MM, Holman SC, et al. Status of methods for assessing bacterial cell surface charge properties based on zeta potential measurements. J Microbiol Meth 2001; 43: 153-164.
10. Suchea S, Christoulakis M, Katsarakis N, et al. Comparative study of zinc oxide and aluminum doped zinc oxide transparent thin films grown by direct current magnetron sputtering. Thin Solid Film 2007; 515: 6562-6566.
11. Wang X, Ou D, Yin J, et al. Proteomic analysis reveals altered expression of proteins related to glutathione metabolism and apoptosis in the small intestine of zinc oxide-supplemented piglets. Amino Acid 2009; 37: 209-218.
12. Sibilano R, Frossi B, Pucillo CE,. Mast cell activation: a complex interplay of positive and negative signaling pathways. Eur J Immunol 2014; 44: 2558-2566.
13. Saluja R, Zoltowska A, Ketelaar ME, et al. IL-33 and Thymic Stromal Lymphopoietin in mast cell functions. Eur J Pharmacol 2015. pii (in press). DOI: 10.1016/j.ejphar.2015.04.047.
14. Kashyap M, Rochman Y, Spolski R, et al. Thymic stromal lymphopoietin is produced by dendritic cells. J Immunol 2011; 187: 1207-1211.
15. Moon PD, Kim HM,. Thymic stromal lymphopoietin is expressed and produced by caspase-1/NF-B pathway in mast cells. Cytokine 2011; 54: 239-243.
16. Redhu NS, Gounni AS,. Function and mechanisms of TSLP/TSLPR complex in asthma and COPD. Clin Exp Allergy 2012; 42: 994-1005.
17. Han NR, Kim HM, Jeong HJ,. The β-sitosterol attenuates atopic dermatitis-like skin lesions through down-regulation of TSLP. Exp Biol Med (Maywood) 2014; 239: 454-464.
18. Jeong HJ, Nam SY, Oh HA, et al. Interleukin-32-induced thymic stromal lymphopoietin plays a critical role in macrophage differentiation through the activation of caspase-1 in vitro. Arthritis Res Ther 2012; 14: R259-R259.
19. Song YH, Nam SY, Choi Y, et al. Socioeconomic impact of traditional Korean medicine, Pyeongwee-San (KMP6) as an anti-allergic inflammatory drug. TANG 2012; 2: e29-e29.
20. Wahab R, Siddiqui MA, Saquib Q, et al. ZnO nanoparticles induced oxidative stress and apoptosis in HepG2 and MCF-7 cancer cells and their antibacterial activity. Colloids Surf B Biointerfaces 2014; 117: 267-276.
21. Kim MH, Jeong HJ,. Zinc oxide nanoparticles suppress LPS-Induced NF-B activation by inducing A20, a aegative regulator of NF-B, in RAW 264.7 macrophages. J Nanosci Nanotechnol 2015; 15: 6509-6515.
22. Song MK, Lee MY, Seo JH, et al. Synthesis of high crystalline al-doped ZnO nanopowers from Al2o3 and ZnO by radio-frequency plasma. J Nanomater 2015; 2015: 1-6.
23. Yoo NJ, Park WS, Kim SY, et al. Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1. Biochem Biophy Res Com 2002; 299: 652-658.
24. Nam SY, Kim HY, Yoou MS, et al. Anti-inflammatory effects of isoacteoside from Abeliophyllum distichum. Immunopharmacol Immunotoxicol 2015; 37: 258-264.
25. Mizuno K, Morizane S, Takiguchi T, et al. Dexamethasone but not tacrolimus suppresses TNF-α-induced thymic stromal lymphopoietin expression in lesional keratinocytes of atopic dermatitis model. J Dermatol Sci 2015; 80: 45-53.
26. Han NR, Oh HA, Nam SY, et al. TSLP induces mast cell development and aggravates allergic reactions through the activation of MDM2 and STAT6. J Invest Dermatol 2014 b; 134: 2521-2530.
27. Jeong HJ, Koo HN, Na HJ, et al. Inhibition of TNF-alpha and IL-6 production by Aucubin through blockade of NF-kappaB activation RBL-2H3 mast cells. Cytokine 2002; 18: 252-259.
28. Jeong HJ, Shin SY, Oh HA, et al. IL-32 up-regulation is associated with inflammatory cytokine production in allergic rhinitis. J Pathol 2011; 224: 553-563.
29. Gauvreau GM, O'Byrne PM, Boulet LP, et al. Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med 2014; 370: 2102-2110.
30. Heng BC, Zhao X, Tan EC, et al. Evaluation of the cytotoxic and inflammatory potential of differentially shaped zinc oxide nanoparticles. Arch Toxicol 2011; 85: 1517-1528.
31. Pan CH, Liu WT, Bien MY, et al. Effects of size and surface of zinc oxide and aluminum-doped zinc oxide nanoparticles on cell viability inferred by proteomic analyses. Int J Nanomed 2014; 9: 3631-3643.
32. Xu M, Fujita D, Kajiwara S, et al. Contribution of physicochemical characteristics of nano-oxides to cytotoxicity. Biomaterials 2010; 31: 8022-8031.
33. Chusuei CC, Wu CH, Mallavarapu S, et al. Cytotoxicity in the age of nano: the role of fourth period transition metal oxide nanoparticle physicochemical properties. Chem Biol Interact 2013; 206: 319-326.
34. Seo JH, Hong BG,. Thermal plasma synthsis of nano-sized powders. Nucl Eng Technol 2012; 44: 9-20.
35. Sahu D, Kannan GM, Vijayaraghavan R,. Size-dependent effect of zinc oxide on toxicity and inflammatory potential of human monocytes. J Toxicol Environ Health A 2014; 77: 177-191.
36. Matsumura M, Nagata M, Nakamura K, et al. Adjuvant effect of zinc oxide on Th2 but not Th1 immune responses in mice. Immunopharmacol Immunotoxicol 2010; 32: 56-62.
37. Chiang HM, Xia Q, Zou X, et al. Nanoscale ZnO induces cytotoxicity and DNA damage in human cell lines and rat primary neuronal cells. J Nanosci Nanotechnol 2012; 12: 2126-2135.
38. Hu CH, Song ZH, Xiao K, et al. Zinc oxide influences intestinal integrity, the expressions of genes associated with inflammation and TLR4-myeloid differentiation factor 88 signaling pathways in weanling pigs. Innate Immun 2014; 20: 478-486.
39. Ou D, Li D, Cao Y, et al. Dietary supplementation with zinc oxide decreases expression of the stem cell factor in the small intestine of weanling pigs. J Nutr Biochem 2007; 8: 820-826.
40. Oyarzun-Ampuero FA, Brea J, Loza MI, et al. A potential nanomedicine consisting of heparin-loaded polysaccharide nanocarriers for the treatment of asthma. Macromol Biosci 2012; 12: 176-183.
41. Pati R, Mehta RK, Mohanty S, et al. Topical application of zinc oxide nanoparticles reduce bacterial skin infection in mice and exhibit antibacterial activity by inducing oxidative stress response and cell membrane disintegration in macrophages. Nanomedicine 2014; 10: 1195-1208.
42. Johnson BM, Fraietta JA, Gracias DT, et al. Acute exposure to ZnO nanoparticles induces autophagic immune cell death. Nanotoxicology 2015; 9: 737-748.
43. Akhtar MJ, Alhadlaq HA, Alshamsan A, et al. Aluminum doping tunes band gap energy level as well as oxidative stress-mediated cytotoxicity of ZnO nanoparticles in MCF-7 cells. Sci Rep 2015; 5: 13876-13876.
44. Tripathy N, Hong TK, Ha KT, et al. Effect of ZnO nanoparticles aggregation on the toxicity in RAW 264.7 murine macrophage. J Hazard Mater 2014; 270: 110-117.
45. Lu W, Senapati D, Wang S, et al. Effect of surface coating on the toxicity of silver nanomaterials on human skin keratinocytes. Chem Phys Lett 2010; 487: 92-96.
46. Xia T, Kovochich M, Liong M, et al. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2008; 2: 2121-2134.
47. Yamanaka K, Tanaka M, Tsutsui H, et al. Skin-specific caspase-1-transgenic mice show cutaneous apoptosis and pre-endotoxin shock condition with a high serum level of IL-18. J Immunol 2000; 165: 997-1003.
48. Sarkar A, Duncan M, Hart J, et al. ASC directs NF-kappaB activation by regulating receptor interacting protein-2 (RIP2) caspase-1 interactions. J Immunol 2006; 176: 4979-4986.
49. McCarthy JV, Ni J, Dixit VM,. RIP2 is a novel NF-kappaB activating and cell death-inducing kinase. J Biol Chem 1998; 273: 16968-16975.